India to Netherlands: Gliclazide Export Trade Route

The India to Netherlands Gliclazide corridor is one of India's established pharmaceutical export routes, with 44 shipments documented worth a combined $87.7M USD. The route is dominated by MYLAN LABORATORIES LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's gliclazide manufacturing sector.

Across 7 active suppliers, the average shipment value stands at $2.0M USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (66%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during October–December, with an average transit time of 25 days port-to-port. The route has recorded an annual growth rate of 33.5%, placing it at rank #9 among India's top gliclazide export destinations globally.

On the import side, key buyers of Indian gliclazide in Netherlands include MYLAN B,V C/0 TJOAPACK,, MYLAN B V, Mylan B V C 0 Tjoapack and 14 others. MYLAN B,V C/0 TJOAPACK, is the single largest importer with 1 shipments valued at $86.1M USD.

India's gliclazide exports to Netherlands are driven primarily by a handful of large-scale manufacturers. MYLAN LABORATORIES LIMITED with 26 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in Netherlands benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MYLAN LABORATORIES LIMITED, S KANT HEALTHCARE LIMITED, MILAN LABORATORIES INDIA PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $2.0M USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as harmless medicines :- gliclazide tablets and gliclazide tablets 80 mg packs 4000sbsp, suggesting that buyers in Netherlands tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, MYLAN B,V C/0 TJOAPACK, is the largest importer with 1 shipments worth $86.1M USD — representing 98% of all gliclazide imports from India on this route. A total of 17 buyers are active on this corridor.